Epidemiology of Intracerebral Hemorrhage (ICH)

October 21, 2024 updated by: Norhan Mohamed Hassan Bakri, Assiut University

Prevalence and Clinical Features of Intracerebral Hemorrhage Among Stroke Patients Admitted to Assiut University Hospital

Exploring the risk factors and associations of intracerebral hemorrhage

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Exploring the clinical characteristics and prevalence of intracerebral hemorrhage in Assiut University

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Nageh Fouly, Professor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Stroke Patients

Description

Inclusion Criteria:

  • both sex
  • Age ≥ 18
  • patients diagnosed with non traumatic hemorrhagic stroke on brain computed tomography scan

Exclusion Criteria:

  • presence of space occupying lesion visible on brain computed tomography scan
  • preceding brain trauma or post traumatic cerebral hemorrhagic stroke
  • presence of ischemic stroke
  • presence hemorrhagic transformation on top of acute ischemic stroke

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Volume of Intracerebral Hemorrhage Among Stroke Patients Admitted to Assiut University Hospital
Time Frame: At time of enrollment of study and after 24 hours
CT data (ABC/2) formula for intracerebral hemorrhage volume
At time of enrollment of study and after 24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Investigators

  • Principal Investigator: Norhan MH Bakri, MD, Assiut University
  • Study Director: Ahmed NasrEldein, Ass.Professor, Assiut University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 30, 2024

Primary Completion (Estimated)

November 29, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

October 14, 2024

First Submitted That Met QC Criteria

October 21, 2024

First Posted (Actual)

October 23, 2024

Study Record Updates

Last Update Posted (Actual)

October 23, 2024

Last Update Submitted That Met QC Criteria

October 21, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 200913

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ICH - Intracerebral Hemorrhage

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe